Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL-Reference-Cited by-同舟云学术

Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL

Published:2019-06-11 Issue:1 Volume:17 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Perfecto-Avalos Yocanxóchitl,Garcia-Gonzalez Alejandro,Hernandez-Reynoso Ana,Sánchez-Ante Gildardo,Ortiz-Hidalgo Carlos,Scott Sean-Patrick,Fuentes-Aguilar Rita Q.,Diaz-Dominguez Ricardo,León-Martínez Grettel,Velasco-Vales Verónica,Cárdenas-Escudero Mara A.,Hernández-Hernández José A.,Santos Arturo,Borbolla-Escoboza José R.,Villela Luis

Funder

CONACyT

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-019-1951-y.pdf

Reference44 articles.

1. Fang C, Xu W, Li J-Y. A systematic review and meta-analysis of rituximab-based immunochemotherapy for subtypes of diffuse large B cell lymphoma. Ann Hematol. 2010;89:1107–13.

2. Lenz G, Wright GW, Emre NCT, Kohlhammer H, Dave SS, Davis RE, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci. 2008;105:13520–5.

3. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.